Advent International’s Definitive Healthcare DH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$51.9M Hold
62,493,676
0.29% 16
2026
Q1
$76.9M Hold
62,493,676
1.81% 9
2025
Q4
$181M Hold
62,493,676
3.74% 5
2025
Q3
$254M Hold
62,493,676
5.11% 5
2025
Q2
$244M Hold
62,493,676
7.91% 4
2025
Q1
$181M Hold
62,493,676
5.72% 5
2024
Q4
$257M Hold
62,493,676
6% 5
2024
Q3
$279M Hold
62,493,676
5.91% 5
2024
Q2
$341M Hold
62,493,676
8.15% 4
2024
Q1
$504M Hold
62,493,676
8.85% 4
2023
Q4
$621M Hold
62,493,676
8.33% 5
2023
Q3
$499M Hold
62,493,676
5.95% 5
2023
Q2
$687M Hold
62,493,676
7.96% 4
2023
Q1
$646M Hold
62,493,676
7.86% 5
2022
Q4
$687M Hold
62,493,676
8.01% 4
2022
Q3
$971M Hold
62,493,676
8.63% 3
2022
Q2
$1.43B Hold
62,493,676
10.02% 3
2022
Q1
$1.54B Hold
62,493,676
9.43% 3
2021
Q4
$1.71B Sell
62,493,676
-2,102,873
-3% -$73.6M 7.1% 3
2021
Q3
$2.77B Buy
+64,596,549
New +$2.87B 12.83% 3

Other funds holding DH

Advent International's DH Position: Q2 2026 in Review

Advent International held its Definitive Healthcare (DH) position steady in Q2 2026 at 62,493,676 shares worth $51.9M. The position accounts for 0.29% of the portfolio, ranked #16.

Advent International first reported a position in DH in Q3 2021 and has held it in 20 quarters since. The position peaked at $2.77B in Q3 2021. 100 funds tracked by Wall St. Rank hold DH as of Q2 2026.

  • Advent International held 62,493,676 shares of Definitive Healthcare worth $51.9M as of Q2 2026.
  • Advent International left its Definitive Healthcare share count unchanged in Q2 2026.
  • Definitive Healthcare made up 0.29% of Advent International's portfolio in Q2 2026, its #16 holding.
  • Advent International first reported a position in Definitive Healthcare in Q3 2021 and has held it in 20 quarters since.
  • Advent International's Definitive Healthcare position peaked at $2.77B in Q3 2021.
  • 100 funds tracked by Wall St. Rank held Definitive Healthcare as of Q2 2026.

Based on Advent International's 13F filing for Q2 2026, filed 14 Aug 2026.